Month: May 2025

Prosafe has been declared the winner of a bidding process for a four-year contract by Petróleo Brasileiro SA (‘Petrobras’) for the provision of the Safe Notos semi-submersible vessel for safety and maintenance support offshore Brazil. Contract award and timing are subject to a formal process during which Petrobras is under no formal obligation to conclude a contract and other bidders may appeal. A contract, if awarded, has a firm period commitment of four years with the operational commencement in September 2026 closely following on from the expiry of the current Safe Notos contract that commenced in Q3 2022. Total value of the contract is approximately USD 204 million. The Safe Notos is a Dynamically Positioned (DP3) semi-submersible safety and maintenance support (UMS) vessel, capable of operating in harsh environments. The Safe Notos...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025 Männedorf, Switzerland, May 12, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today provided a qualitative update on its performance for the first quarter of 2025.On March 12, 2025, Tecan indicated a decline in sales in local currencies for the first half of the year. In line with expectations, sales in the first quarter declined within a mid-single-digit percentage range in local currencies. The Life Sciences Business segment delivered a solid performance, with sales in local currencies close to the prior-year level. This development was supported by increased sales into the clinical diagnostics segment, particularly for genomic...

Hepsor AS subsidiary Hepsor 3Torni OÜ signed a real rights contract on April 30, 2025, under which 20 apartments in the Ojakalda Kodud development project (Paldiski mnt 227C, Tallinn) were sold to the company’s other shareholder, Artex KV OÜ. The transaction amount was four million euros, excluding value-added tax. The transaction was carried out under market conditions, and the average price per square meter of the apartments sold corresponded to the pricing level of comparable units previously sold within the same development. Hepsor 3Torni OÜ will continue to sell the remaining 20 apartments owned by the company in accordance with the original development project strategy. Within the framework of the Ojakalda Kodud development project, three apartment buildings with a total of 101 apartments have been completed, of which 61 have already...

SINGAPORE, May 10, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that the X account of its CEO, Roger Hamilton (X handle: @rogerhamilton), has been compromised. The hackers posted false information without the Company’s knowledge or consent regarding an alleged token launch by the Company. Any posts, solicitations or other messages allegedly announcing this are false and must not be relied upon. The Company and Mr. Hamilton urge the public and all Genius Group investors, partners and customers to disregard all posts and private messages they receive from this account, from yesterday through to when there is affirmative confirmation from the Company’s official accounts (X handles: @GeniusGroupLtd_ and @geniusacademyai)...

MONTREAL, May 10, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”) announces with deep sadness the passing of its founder Herschel Segal in Montreal, Québec on Tuesday, May 6, 2025. Herschel Segal was a pioneering Canadian entrepreneur whose career shaped two iconic retail brands. He was the founder of Le Château, a fashion retailer that became a mainstay in Canadian shopping culture for decades. In 2008, he co-founded DAVIDsTEA, transforming the specialty tea category with a bold, modern retail concept that introduced a new generation to the world of tea. Herschel Segal brought vision, determination, and a strong belief in customer connection to every venture he led. At DAVIDsTEA, he championed accessibility, innovation, and a sense of community — principles that continue to define the...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response Data contribute to growing body of support around the anti-fibrotic activity of EFX in patients with pre-cirrhotic MASH SOUTH SAN FRANCISCO, Calif., May 10, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced results from new analyses of the 96-week Phase 2b HARMONY trial of efruxifermin (EFX) in patients with pre-cirrhotic (F2-F3 fibrosis) metabolic dysfunction-associated steatohepatitis (MASH) in an oral presentation and a poster presentation at the European Association for the Study of the Liver (EASL) Congress 2025 taking place May...

Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL Congress 65% of patients with clinically significant portal hypertension (CSPH) at baseline moved into lower risk categories by year two Patients achieved a mean 6.7 kPa reduction in liver stiffness, which was statistically significant compared to baselineCONSHOHOCKEN, Pa., May 10, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced positive two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra. Patients (n=122) in the study achieved significant improvements...